GGrantIndex
Sort

1,049,261 grants matching t cell

Papova Virus Transforming Mechanisms

$2,776,746
David Morse Livingston · Dana-Farber Cancer Inst · P01 · FY2012 · CA

Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration

$2,776,711
Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · RF1 · FY2017 · AG

"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"

$2,776,459
Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2020 · HG

PRECIOUS METAL FREE REGENERATIVE HYDROGEN ELECTRODE FOR UNITIZED REGENERATIVE FUEL CELLS (URFCS)

$2,776,323
Pajarito Powder Llc · · FY2017 · Department of Energy

Center for the Spatiotemporal Modeling of Cell Signaling (STMC)

$2,776,118
Janet M Oliver · University Of New Mexico · P50 · FY2011 · GM

Environmental Microbial and Mammalian Biomolecular Responses to AhR Ligands

$2,776,059
Norbert E Kaminski · Michigan State University · P42 · FY2014 · ES

Explosive Evolution Under Stress: The Driving Forces of Cancer Dynamics (Main)

$2,775,982
Robert H. Austin · Princeton University · U54 · FY2012 · CA

Genomics of Acute Myelogenous Leukemia

$2,775,922
Timothy J Ley · Washington University · P01 · FY2009 · CA

1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)

$2,775,824
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · UH3 · FY2020 · HL

Drug Abuse Research Center

$2,775,719
Solomon H Snyder · Johns Hopkins University · P50 · FY2014 · DA

Drug Abuse Research Center

$2,775,719
Solomon H Snyder · Johns Hopkins University · P50 · FY2012 · DA

Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses

$2,775,679
James E Crowe · University Of Texas Med Br Galveston · U19 · FY2020 · AI

Biochemical Basis of T Cell Activation

$2,775,630
Lawrence Samelson · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

New Tools for Exploring the Dynamic Interactome(RMI)

$2,775,587
Rockefeller University · U54 · FY2005 · RR

NEW TOOLS FOR EXPLORING THE DYNAMIC INTERACTOME(RMI)

$2,775,587
Rockefeller University · U54 · FY2005 · RR

Synergies among inhibitory receptors in tolerance and disease

$2,775,439
Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI

COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA

$2,775,400
Salim S Abdool Karim · University Of Kwazulu-Natal · U19 · FY2007 · AI

DEVELOPING ANIMAL MODELS FOR OPTIMIZING THE MUSCULOSKELETAL REPAIR POTENTIAL OF EMERGING HUMAN PROGENITOR CELL THERAPIES

$2,775,175
University Of Connecticut Health Center · · FY2011 · Department of Defense

Aging-related hematopoietic stem cell intrinsic and microenvironmental signals in AML transformation

$2,775,137
Stavroula Kousteni · Columbia University Health Sciences · P01 · FY2024 · CA

Viral Hemorrhagic Fevers: Disease Modeling and Transmission

$2,775,051
Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Protection of Ischemic Myocardium

$2,774,979
Roberto Bolli · University Of Louisville · P01 · FY2017 · HL

Pathogenic Mechanisms in Spondyloarthritis

$2,774,828
Robert Colbert · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR

Science and Technology Resources

$2,774,817
David Goldstein · Division Of Basic Sciences - Nci · ZIK · FY2017 · CA

Local neuronal drive and neuromodulatory control of activity in the pial neurovascular circuit

$2,774,791
Anna Devor · Boston University (Charles River Campus) · U19 · FY2022 · NS

DEFINITION PHASE ONLY. EVIDENCE HAS ACCUMULATED FROM ANIMAL STUDIES THAT THE CENTRAL NERVOUS SYSTEM UNDERGOES DELETERIOUS CHANGES AFTER EXPOSURE TO CHARGED PARTICLE RADIATION SUCH AS PROTONS AND HIGH ATOMIC NUMBER ATOMIC NUCLEI THAT ARE FOUND IN SPACE AS GALACTIC COSMIC RAYS AND SOLAR PARTICLE EVENTS. OBSERVED CHANGES INCLUDE INFLAMMATION OXIDATIVE STRESS LOSS OF NEURON (DENDRITE) BRANCHES AND CONNECTIONS (SYNAPSES) ALTERED SIGNALING MOLECULES ALTERED ELECTRICAL PROPERTIES LOSS OF BLOOD VESSELS AND IMPAIRED BEHAVIORAL PERFORMANCE. IF HUMANS RESPOND TO CHARGED PARTICLES IN THE SAME WAY AS ANIMALS THEN IT IS POSSIBLE THAT DELETERIOUS CHANGES MAY BE SUFFICIENT TO CAUSE COGNITIVE AND OTHER BEHAVIORAL IMPAIRMENTS THAT COULD COMPROMISE SPACEFLIGHT MISSIONS AND ASTRONAUT HEALTH. THE CURRENT EVIDENCE IS BASED PRIMARILY ON SHORT EXPOSURES TO SINGLE RADIATION TYPES. HOWEVER SPACE RADIATION IS A COMPLEX MIXTURE OF THESE PARTICLES AND EXPOSURES ACCUMULATE GRADUALLY OVER THE COURSE OF MISSIONS. IT IS WELL ESTABLISHED IN RADIATION BIOLOGY THAT REDUCTION OF THE DOSE RATE CAN HAVE A PROFOUND EFFECT ON THE OUTCOME. THEREFORE TO BETTER SIMULATE THE SPACE ENVIRONMENT WE PROPOSE TO EXPOSE ADULT MICE TO EITHER 0.5 GY PROTONS OR 0.25 AND 0.5 GY MIXTURES OF HELIUM OXYGEN AND SILICON PARTICLES IN 2:1:1 RATIOS AS THEY ARE FOUND IN SPACE. THEN WE WILL DELIVER THE EXPOSURES OVER LONG TIME PERIODS (UP TO 6 WEEKS) IN MULTIPLE SHORT EXPOSURES (FRACTIONS) COMPATIBLE WITH PARTICLE ACCELERATOR OPERATIONS. THESE RESULTS WOULD BE COMPARED TO RESULTS FROM ACUTE EXPOSURES TO ESTABLISH THE DOSE RATE EFFECTIVENESS FACTORS (DREFS) WHICH ARE NEEDED FOR RISK ESTIMATION FOR ASTRONAUT HEALTH. WE PREDICT THAT THE HIGH NUMBERS (FLUENCE) OF PROTONS WILL RESULT IN MULTIPLE TRAVERSALS OF CELLS WITHIN SHORT TIMES THAT MAY ELICIT INTERACTING BIOLOGICAL RESPONSES WHEREAS THE LOWER FLUENCE OF HIGHER CHARGED IONS WILL RESULT IN RARE INDEPENDENT EVENTS. DREFS>1 ARE PREDICTED FOR PROTONS AND DREFS ~1 ARE PREDICTED FOR HIGH Z PARTICLES. WE WILL ALSO COMPARE THE "PROTRACTED" EXPOSURES OF CHARGED PARTICLE MIXTURES TO GAMMA RAYS TO DETERMINE WHETHER THEY HAVE EQUIVALENT DOSE EFFECTS OR ARE MORE EFFECTIVE. THE RELATIVE BIOLOGICAL EFFECTIVENESS FACTOR (RBES) WILL BE DERIVED. THESE RBES ARE UTILIZED IN PREDICTING DENSELY IONIZING RADIATION EFFECTS IN HUMANS FOR WHOM ONLY GAMMA RAY AND X-RAY DATA ARE AVAILABLE WITH THE ASSUMPTION THAT THE RATIOS OBTAINED IN ANIMAL MODELS ARE REALISTIC SURROGATES FOR HUMANS. WE WILL TEST BOTH MALE AND FEMALE ANIMALS AS THEIR RESPONSES ARE NOT IDENTICAL AND THE ASTRONAUT POPULATION IS OF MIXED GENDER. FOR EACH OF THE EXPOSURE REGIMENS WE WILL CONDUCT A BATTERY OF BEHAVIOR TESTS MEASURE ELECTROPHYSIOLOGICAL PROPERTIES IN TISSUE SLICES AND QUANTIFY CHANGES IN THE STRUCTURE AND COMPOSITION OF THE TISSUE USING STATE OF THE ART BIOCHEMICAL HISTOCHEMICAL AND MICROSCOPY METHODS. THIS WILL ALLOW US TO IDENTIFY THE UNDERLYING PHYSIOLOGICAL CHANGES MOST SENSITIVE TO DOSE RATE AND RADIATION QUALITY AND HOW THEY COMBINE TO PRODUCE BEHAVIORS THAT ARE ADAPTIVE OR MALADAPTIVE. TOGETHER THE DATA GENERATED BY THE PROJECT WILL ENHANCE NASAS ABILITY TO TRANSLATE ANIMAL ASSESSMENTS OF CNS STRUCTURE AND FUNCTION TO HUMANS AND TO UPDATE RISK ESTIMATES BASED ON SINGLE RADIATION SPECIES HIGH DOSE RATE IRRADIATION PROTOCOLS TO HIGHER FIDELITY SPACE-LIKE EXPOSURES OF CHARGED PARTICLE MIXTURES DELIVERED AT DOSE RATES APPROACHING THOSE OBSERVED IN SPACE.

$2,773,956
Loma Linda University · · FY2020 · National Aeronautics and Space Administration